GRTX Projected Dividend Yield
Galera Therapeutics Inc ( OTCBB : GRTX )Galera Therapeutics, Inc. is a biopharmaceutical company focused on developing a pipeline of novel, therapeutic candidates that have the potential to transform radiotherapy in cancer. Co.'s lead product candidate, avasopasem manganese (avasopasem), is a highly selective small molecule dismutase mimetic that the Co. is developing for the reduction of severe oral mucositis (SOM) in patients with head and neck cancer (HNC), the reduction of esophagitis in patients with lung cancer, and the reduction of cisplatin-induced kidney damage in patients with cancer. 20 YEAR PERFORMANCE RESULTS |
GRTX Dividend History Detail GRTX Dividend News GRTX Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |